The Net Margin of Bridge Biotherapeutics Inc (288330.KQ) is -42320.90%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2023-12-31 | -42320.90% |
| 2022-12-31 | -1379.08% |
| 2021-12-31 | -1365.70% |
| 2020-12-31 | -303.34% |
| 2019-12-31 | 2.27% |